Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $76.33.
A number of analysts have recently weighed in on NHI shares. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Truist Financial boosted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Finally, Bank of America initiated coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company.
View Our Latest Analysis on NHI
Institutional Trading of National Health Investors
National Health Investors Stock Up 0.6 %
National Health Investors stock opened at $72.76 on Friday. The firm has a market capitalization of $3.30 billion, a P/E ratio of 25.00, a P/E/G ratio of 4.87 and a beta of 1.04. The company has a 50-day simple moving average of $77.01 and a 200-day simple moving average of $75.53. National Health Investors has a one year low of $51.59 and a one year high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29.
National Health Investors (NYSE:NHI – Get Free Report) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). The firm had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the company posted $1.08 EPS. As a group, equities analysts expect that National Health Investors will post 4.42 earnings per share for the current year.
National Health Investors Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.95%. National Health Investors’s payout ratio is currently 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- What Are the U.K. Market Holidays? How to Invest and Trade
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- How to Invest in Insurance Companies: A Guide
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Canada Bond Market Holiday: How to Invest and Trade
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.